Literature DB >> 36107242

Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.

Cui Zhai1, Nana Zhang2, Jian Wang3, Meng Cao1, Jing Luan1, Huan Liu1, Qianqian Zhang3, Yanting Zhu4, Yuxin Xue1, Shaojun Li5.   

Abstract

PURPOSE: It has been shown that activation of autophagy promotes the development of pulmonary arterial hypertension (PAH). Meanwhile, forkhead box M1 (FOXM1) has been found to induce autophagy in several types of cancer. However, it is still unclear whether FOXM1 mediates autophagy activation in PAH, and detailed mechanisms responsible for these processes are indefinite.
METHOD: PAH was induced by a single intraperitoneal injection of monocrotaline (MCT) to rats. The right ventricle systolic pressure (RVSP), right ventricular hypertrophy index (RVHI), percentage of medial wall thickness (%MT), α-smooth muscle actin (α-SMA) staining, and Ki67 staining were performed to evaluate the development of PAH. The protein levels of FOXM1, phospho-focal adhesion kinase (p-FAK), FAK, and LC3B were determined by immunoblotting or immunohistochemistry.
RESULTS: FOXM1 protein level and FAK activity were significantly increased in MCT-induced PAH rats, this was accompanied with the activation of autophagy. Pharmacological inhibition of FOXM1 or FAK suppressed MCT-induced autophagy activation, decreased RVSP, RVHI and %MT in MCT-induced PAH rats, and inhibited the proliferation of pulmonary arterial smooth muscle cells and pulmonary vessel muscularization in MCT-induced PAH rats.
CONCLUSION: FOXM1 promotes the development of PAH by inducing FAK phosphorylation and subsequent activation of autophagy in MCT-treated rats.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autophagy; Focal adhesion kinase (FAK); Forkhead box M1 (FOXM1); Pulmonary arterial hypertension; Pulmonary vascular remodeling

Mesh:

Substances:

Year:  2022        PMID: 36107242     DOI: 10.1007/s00408-022-00569-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  34 in total

Review 1.  Autophagy fights disease through cellular self-digestion.

Authors:  Noboru Mizushima; Beth Levine; Ana Maria Cuervo; Daniel J Klionsky
Journal:  Nature       Date:  2008-02-28       Impact factor: 49.962

Review 2.  The role of autophagy in pulmonary hypertension: a double-edge sword.

Authors:  Rui Chen; Meiping Jiang; Bo Li; Wei Zhong; Zhongqun Wang; Wei Yuan; Jinchuan Yan
Journal:  Apoptosis       Date:  2018-10       Impact factor: 4.677

Review 3.  Eaten alive: a history of macroautophagy.

Authors:  Zhifen Yang; Daniel J Klionsky
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

Review 4.  Pulmonary arterial hypertension: Basic knowledge for clinicians.

Authors:  Diana Santos-Ribeiro; Pedro Mendes-Ferreira; Carolina Maia-Rocha; Rui Adão; Adelino F Leite-Moreira; Carmen Brás-Silva
Journal:  Arch Cardiovasc Dis       Date:  2016-08-29       Impact factor: 2.340

5.  Identification of new prognostic factors of pulmonary hypertension.

Authors:  Yutaka Miura; Yoshihiro Fukumoto; Koichiro Sugimura; Minako Oikawa; Makoto Nakano; Shunsuke Tatebe; Saori Miyamichi; Kimio Satoh; Hiroaki Shimokawa
Journal:  Circ J       Date:  2010-07-10       Impact factor: 2.993

Review 6.  FoxM1: Repurposing an oncogene as a biomarker.

Authors:  Deeptashree Nandi; Pradeep Singh Cheema; Neha Jaiswal; Alo Nag
Journal:  Semin Cancer Biol       Date:  2017-09-10       Impact factor: 15.707

Review 7.  Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.

Authors:  Tamara Tajsic; Nicholas W Morrell
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

Review 8.  Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging.

Authors:  Kanchan Phadwal; Alexander Scarth Watson; Anna Katharina Simon
Journal:  Cell Mol Life Sci       Date:  2012-06-05       Impact factor: 9.261

Review 9.  A review of therapeutic agents for the management of pulmonary arterial hypertension.

Authors:  Stella S Hahn; Mina Makaryus; Arunabh Talwar; Mangala Narasimhan; Gulrukh Zaidi
Journal:  Ther Adv Respir Dis       Date:  2016-09-19       Impact factor: 4.031

10.  Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation.

Authors:  Lu Long; Xudong Yang; Mark Southwood; Junyu Lu; Stefan J Marciniak; Benjamin J Dunmore; Nicholas W Morrell
Journal:  Circ Res       Date:  2013-02-27       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.